Ember Therapeutics, Inc. Share Price

Stocks

16/19/16	Viscogliosi Brothers LLC cancelled the acquisition of OP-1 Portfolio Program from Ember Therapeutics, Inc..	CI
16/18/16	Viscogliosi Brothers LLC entered into a letter of intent to acquire OP-1 Portfolio Program from Ember Therapeutics, Inc..	CI
08/16/08	Ember Therapeutics, Inc. acquired the assets of of Dermasilk Brands, Inc. from Midwood Distributors, Inc. for $1.3 million.	CI
06/16/06	Knight Therapeutics Inc. and Ember Therapeutics, Inc. Expand Distribution Partnership	CI
21/16/21	Ember Therapeutics, Inc. entered into a definitive agreement to acquire the assets of Migralex, Inc. for $0.87 million.	CI
16/16/16	Ember Therapeutics, Inc. acquired ICX-RHY/Vavelta from Intercytex Limited for $1.1 million.	CI
24/16/24	American Home Alliance Corp will Change its Ticker to EMBT from AHLL	CI
24/16/24	AMERICAN HOME ALLIANCE CORP will Change its Name to Ember Therapeutics, Inc	CI
03/16/03	Ember Therapeutics, Inc. acquired American Home Alliance Corp. in a reverse merger transaction.	CI
20/15/20	Ember Therapeutics, Inc. Announces Initial Positive Results from a Phase 2 Trial of BMP-7	CI
12/15/12	Mariel Therapeutics, Inc. acquired Ember Therapeutics, Inc. from Third Rock Ventures II, L.P. of Third Rock Ventures II, L.P. and others for $6 million.	CI
31/14/31	Ember Therapeutics, Inc. acquired Worldwide License of BMP-7 and OP-1 Portfolio from Stryker Corporation.	CI
27/12/27	Ember Therapeutics, Inc. Announces Publication of Key Preclinical Data Demonstrating Inhibition of Transient Receptor Potential Vanilloid	CI

29/22/29	Alternative Liquidity Index LP Announces an Extension of the Tender Offer for Ember Therapeutics, Inc.	AQ
19/21/19	Moore Kuehn Encourages EMBT, VSAT, IHC and CSPR Investors to Contact Law Firm	PR

Employees

Sector